Investigating Long-term Health Effects and Complications in COVID-19 Recoveries

COVID-19 Patients Clinical Trial

Official title:

A Study of the Trajectory of Overall Systemic Health Outcomes and Potential Complications in Recovered COVID-19 Patients.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06349720
• Other study ID #: KF-2023-355
• Status: Recruiting
• Start date: June 7, 2023
• Est. completion date: June 7, 2024

Study information

• Verified date: April 2024
• Source: Capital Medical University
• Contact: Zhaohui Tong, Doctor
• Phone: +86 139 1093 0309
• Email: 13910930309[@]163.com
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Clarify the incidence of functional impairments in cured COVID-19 patients and identify influencing factors. Build a multi-omics database for COVID-19 patients in the recovery period to elucidate the biological biomarkers and targets associated with functional impairments. Comprehensive exploration of the long-term prognosis, complications, sequelae, and risk factors of COVID-19 patients after Omicron infection, as well as their immune characteristics. Compare the impact of different strains of the COVID-19 virus on prognosis and immune response. Develop comprehensive rehabilitation intervention strategies for COVID-19 patients with functional impairments and evaluate the impact of different intervention methods on their prognosis. Based on clinical data, multi-omics data, and precise rehabilitation assessment data, construct predictive models for prognosis and rehabilitation effectiveness in COVID-19, providing scientific evidence for the implementation of effective COVID-19 rehabilitation measures.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 17000
• Est. completion date: June 7, 2024
• Est. primary completion date: June 7, 2024
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

Inclusion Criteria:

1. Meets the diagnostic criteria for confirmed cases according to the "Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 10)";

2. The participant or the authorized representative understands the entire purpose of the study, voluntarily participates in the research, and signs an informed consent form, ensuring that they can complete regular assessments at the relevant participating units and receive necessary rehabilitation treatment as required;

3. Agrees to the researcher's collection of their peripheral blood samples, saliva samples, and urine samples for the needs of the study.

Exclusion Criteria:

1. Women who are pregnant or breastfeeding;

2. Individuals with mental disorders that affect normal communication;

3. Those who refuse to participate in regular assessments and rehabilitation treatments;

4. Individuals who decline to provide specimens required for the study.

Related Conditions & MeSH terms

• COVID-19
• COVID-19 Patients

Intervention

Behavioral:
• respiratory rehabilitation
Emote respiratory rehabilitation:Patients wear monitoring devices and upload real-time monitoring data such as vital signs through the FREE rehabilitation app installed on their personal phones. Medical staff monitor changes in patients' vital signs in real time through the FREE rehabilitation app on the medical end, and adjust respiratory rehabilitation plans based on their phone or video guidance. Outpatient respiratory rehabilitation:Traditional outpatient respiratory rehabilitation is based on a group approach, with individualized intensity determined based on baseline assessment results, and is conducted under supervision twice a week for a period of 12 weeks.

Locations

Country	Name	City	State
China	Beijing Institute of Respiratory Medicine	Beijing	Beijing

Sponsors (1)

Lead Sponsor	Collaborator
Zhaohui Tong

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Immunological characteristics associated with functional impairments in COVID-19 convalescent patients		6 months, 12 months and 24 months
Primary	Changes in laboratory examination indicators		6 months, 12 months and 24 months
Primary	High-resolution CT of the chest		6 months, 12 months and 24 months
Primary	Pulmonary function test		3 months, 12 months
Primary	Multi-omics changes and characteristics associated with functional impairments in COVID-19 convalescent patients		6 months, 12 months and 24 months
Primary	Inflammatory factors related to body dysfunction in COVID-19 rehabilitation patients		6 months, 12 months and 24 months
Primary	Regular rehabilitation assessment following respiratory rehabilitation intervention in COVID-19 patients		6 months, 12 months and 24 months